| Symbol: |
NDP
|
| Description: |
Norrie disease (pseudoglioma) [Source:HGNC Symbol;Acc:7678]
|
| Location: |
ChrX:43808022-43832750[-]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:209
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| NDP |
NSC 58903 |
0.035 |
Down |
| NDP |
9-AC |
0.021 |
Down |
| NDP |
NSC 604979 |
0.027 |
Down |
| NDP |
RAPAMYCIN PRODRUG |
0.036 |
Down |
| NDP |
Camptothecin lysinate HCl |
0.014 |
Down |
| NDP |
1H-Dibenz[de,h]isoquinoline-1,3-dione, 2,2'- [(1,2-ethanediyldiamino)bis(1,3-propanediyl)] bis[2,3-dihydro-, dihydrochloride |
0.022 |
Down |
| NDP |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.048 |
Down |
| NDP |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.013 |
Down |
| NDP |
14-FLUORO-4-DEMETHOXYDAUNORUBICIN |
0.046 |
Down |
| NDP |
9-AMINO-20-CAMPTOTHECIN |
0.004 |
Down |
| NDP |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.016 |
Down |
| NDP |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.01 |
Down |
| NDP |
(E)Methyl-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoate |
0.001 |
Down |
| NDP |
NSC 641594 |
0.002 |
Down |
| NDP |
Choline, hydroxide, 3-methoxy- 2-[methyl(octadecyl)amino]propyl hydrogen phosphate, inner salt |
0.008 |
Down |
Expression pattern: Sensitivity / Resistance
Total:14 Current:3
First Prev Next Last 
|
| SNP:
~ Export ~
|
Records:11
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
| miRNA:
~ Export ~
|
Records:17
Total:2 Current:1
[First] [Prev]  Next Last 
|